MedTrace Logo

Health Effect of Canola Oil Consumption in Shift Workers

NCT03977558 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2019-06-10

No results posted yet for this study

Summary

Shift work is associated with a higher risk of the development of cardiometabolic syndrome (CMtS) than in people working only during the day. One of the factors predisposing to the development of the CMtS in shift workers is an inappropriate composition of their diet. It was observed that the shift workers diet is characterized by a higher intake of saturated fatty acids (SFA) and a lower consumption of unsaturated fatty acids. One potential way to reduce the risk of CMtS in this study group seems to be a modification of their everyday diet by excluding the products of animal origin (e.g. butter) with simultaneously including vegetable oils (i.e. canola oil). The aim of the study is to evaluate the effect of replacement in the everyday diet of saturated fats (butter) with unsaturated fats (canola oil-based spread and canola oil added to main meals) in centrally obese shift workers on changes in body weight and body composition parameters as well as on changes in CMtS markers.

Conditions

  • Shift-Work Related Sleep Disturbance
  • Metabolic Syndrome
  • Diet Modification
  • Work-Related Condition

Interventions

BEHAVIORAL

Intervention group

Isocaloric diet including \~50g canola oil

BEHAVIORAL

Control group

ESC/EAS Guidelines for the management of dyslipidemias

Sponsors & Collaborators

  • Poznan University of Life Sciences

    lead OTHER

Principal Investigators

  • Agnieszka Kuleta-Koberska, Msc · Poznan University of Life Sciences

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
60 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-10-30
Primary Completion
2019-10-30
Completion
2019-12-31

Countries

  • Poland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03977558 on ClinicalTrials.gov